Try
REVVITY, INC.
RVTYUnited States
122 filed reports · 726 financial concepts · 2 earnings calls · 4 media appearances
Filed reports
122 reports · Apr 2012 to Jul 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 348 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 64 | 257 | Apr 2012 to Jul 2026 |
| Quarterly · 10-QSEC EDGAR | 44 | 8,747 | Apr 2012 to Jul 2026 |
| Annual · 10-KSEC EDGAR | 14 | 9,878 | Dec 2012 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jul 5, 2026 | Aug 11, 2026 | 408 | Open |
| FY2026 Q2 | 8-K | Jul 5, 2026 | Aug 4, 2026 | 6 | Open |
| FY2026 Q2 | 10-Q | Apr 5, 2026 | May 12, 2026 | 280 | Open |
| FY2026 Q2 | 8-K | Apr 5, 2026 | May 5, 2026 | 4 | Open |
| FY2025 | 10-K | Dec 28, 2025 | Feb 24, 2026 | 1,209 | Open |
| FY2025 Q4 | 8-K | Dec 28, 2025 | Feb 2, 2026 | 4 | Open |
| FY2025 Q4 | 8-K | Dec 28, 2025 | Jan 13, 2026 | 9 | Open |
| FY2025 Q3 | 10-Q | Sep 28, 2025 | Nov 4, 2025 | 266 | Open |
| FY2025 Q3 | 8-K | Sep 28, 2025 | Oct 27, 2025 | 6 | Open |
| FY2025 Q2 | 10-Q | Jun 29, 2025 | Aug 5, 2025 | 158 | Open |
| FY2025 Q2 | 8-K | Jun 29, 2025 | Jul 28, 2025 | 6 | Open |
| FY2025 Q1 | 10-Q | Mar 30, 2025 | May 6, 2025 | 158 | Open |
Financial data
726 concepts · 18,882 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial684 concepts · 16,495 facts · May 2008 to Jul 2026
- Cash and cash equivalents at carrying value79 · Jan 2011 to Jul 2026
- Fair value measurement with unobservable inputs reconciliations recurring basis liability value79 · Jan 2011 to Jul 2026
- Amortization of financing costs and discounts78 · Jan 2011 to Jul 2026
- Comprehensive income net of tax78 · Jan 2011 to Jul 2026
- Depreciation depletion and amortization78 · Jan 2011 to Jul 2026
- Effect of dilutive securities, Restricted stock78 · Jan 2011 to Jul 2026
- Effect of dilutive securities, Stock options78 · Jan 2011 to Jul 2026
- Fair value measurement with unobservable inputs reconciliation recurring basis liability period increase decrease78 · Jan 2011 to Jul 2026
- Fair value measurement with unobservable inputs reconciliation recurring basis liability settlements78 · Jan 2011 to Jul 2026
- Income tax expense benefit78 · Jan 2011 to Jul 2026
- Increase decrease in accounts payable78 · Jan 2011 to Jul 2026
- Increase decrease in accounts receivable78 · Jan 2011 to Jul 2026
- Increase decrease in inventories78 · Jan 2011 to Jul 2026
- Investment income interest78 · Jan 2011 to Jul 2026
- Net cash provided by used in financing activities78 · Jan 2011 to Jul 2026
- Net cash provided by used in investing activities78 · Jan 2011 to Jul 2026
- Net cash provided by used in operating activities78 · Jan 2011 to Jul 2026
- Net income loss78 · Jan 2011 to Jul 2026
- Nonoperating income expense78 · Jan 2011 to Jul 2026
- Operating income loss78 · Jan 2011 to Jul 2026
- Other comprehensive income unrealized holding gain loss on securities arising during period net of tax78 · Jan 2011 to Jul 2026
- Payments for repurchase of common stock78 · Jan 2011 to Jul 2026
- Payments of dividends common stock78 · Jan 2011 to Jul 2026
- Payments to acquire property plant and equipment78 · Jan 2011 to Jul 2026
Segment28 concepts · 1,650 facts · Jan 2011 to Jul 2026
- Revenue559 · Jan 2011 to Jul 2026
- Operating income loss157 · Jan 2011 to Oct 2022
- Goodwill149 · Jan 2012 to Apr 2026
- Goodwill foreign currency translation gain loss99 · Jan 2016 to Jul 2026
- Discovery & Analytical Solutions91 · Jan 2012 to Dec 2025
- Life Sciences71 · Jan 2021 to Jul 2026
- Depreciation depletion and amortization66 · Jan 2011 to Dec 2023
- Product revenue55 · Jan 2011 to Apr 2018
- Services revenue55 · Jan 2011 to Apr 2018
- Total Assets43 · Jan 2012 to Dec 2023
- Depreciation42 · Jan 2023 to Jul 2026
- Discontinued operation gain loss from disposal of discontinued operation before income tax41 · Jan 2011 to Mar 2014
- Payments to acquire property plant and equipment38 · Jan 2017 to Dec 2023
- Payments to acquire productive assets33 · Jan 2012 to Dec 2017
- Intangible Assets (excluding Goodwill)24 · Jan 2012 to Jan 2022
- Operating Income24 · Apr 2011 to Jul 2017
- Goodwill translation adjustments23 · Jan 2012 to Jul 2016
- Restructuring costs21 · Dec 2023 to Jul 2026
- Depreciation & Amortization18 · Jan 2012 to Dec 2023
- Additions to noncurrent assets12 · Jan 2011 to Dec 2012
- Capital Expenditures8 · Dec 2014 to Dec 2023
- Diagnostics6 · Dec 2025 to Jul 2026
- Discontinued operation tax effect of discontinued operation5 · Jan 2011 to Dec 2012
- Advanced Chemistry Development Inc.4 · Apr 2026 to Jul 2026
Geography2 concepts · 292 facts · Jan 2011 to Jul 2026
- Revenue288 · Jan 2011 to Jul 2026
- Revenue (excluding assessed tax)4 · Dec 2018 to Jan 2021
Guidance10 concepts · 259 facts · Apr 2012 to Aug 2026
- EPS (Diluted) Guidance128 · Apr 2012 to Aug 2026
- Revenue Guidance80 · Jan 2020 to Aug 2026
- Revenue Growth Guidance24 · Oct 2020 to Aug 2026
- EPS (Diluted) Growth Guidance6 · Apr 2015 to Nov 2015
- EPS (Diluted) Guidance (Adjusted (non-GAAP))5 · Apr 2013 to Jan 2022
- EPS (Diluted) Guidance (Adjusted, pro forma)4 · Nov 2022
- Revenue Growth Guidance (Non-COVID; Organic)4 · Jan 2022
- Revenue Guidance (Pro forma)4 · Nov 2022
- Effective Tax Rate Guidance2 · Aug 2026
- Revenue Growth Guidance (Organic)2 · Jan 2022
Product2 concepts · 186 facts · Jan 2017 to Jul 2026
- Cost of goods and services sold (US GAAP)94 · Jan 2017 to Jul 2026
- Revenue92 · Jan 2017 to Jul 2026
Segments
2,128 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments25 members · 1,650 facts
- Diagnostics485 · Dec 2014 to Jul 2026
- Discovery Analytical Solutions311 · Dec 2014 to Sep 2025
- Life Sciences187 · Jan 2022 to Jul 2026
- Human Health171 · Jan 2011 to Oct 2016
- Corporate108 · Jan 2011 to Dec 2025
- Environmental health64 · Apr 2011 to Jul 2017
- Discovery analytical solutions49 · Jan 2016 to Dec 2023
- Diagnostics49 · Jan 2016 to Apr 2026
- Human health35 · Jan 2012 to Oct 2016
- All Segments32 · Jan 2011 to Dec 2023
- Segment Discontinued Operations23 · Jan 2011 to Dec 2019
- All segments20 · Jan 2012 to Dec 2023
- Other Discontinued Operations18 · Jan 2011 to Mar 2014
- Life sciences18 · Jan 2023 to Apr 2026
- Diagnostics16 · Jan 2016 to Dec 2023
- Corporate Reconciling Item14 · Jan 2023 to Jul 2026
- Photoflash Business14 · Jan 2011 to Mar 2014
- Corporate13 · Jan 2012 to Dec 2023
- Illumination And Detection Solutions9 · Jan 2011 to Dec 2012
- Corporate Expenses4 · Mar 2025 to Jul 2026
- Technical Services Business3 · Jan 2012 to Dec 2013
- Life sciences2 · Jan 2023 to Dec 2023
- Semiconductor Business2 · Jan 2012
- Segment discontinued operations2 · Dec 2013 to Dec 2014
- Ids And Photoflash Businesses1 · Jan 2011
Statement geographicalsrt:StatementGeographicalAxis16 members · 214 facts
- Americas42 · Apr 2018 to Jul 2026
- Europe42 · Apr 2018 to Jul 2026
- Asia41 · Apr 2018 to Jul 2026
- Other International12 · Jan 2017 to Dec 2025
- Total International12 · Jan 2017 to Dec 2025
- CN10 · Jan 2017 to Dec 2025
- GB10 · Jan 2017 to Dec 2025
- US10 · Jan 2017 to Dec 2025
- DE8 · Jan 2017 to Dec 2025
- FR5 · Jan 2017 to Jan 2021
- IN5 · Jan 2017 to Jan 2021
- IT5 · Jan 2017 to Jan 2021
- JP5 · Jan 2017 to Jan 2021
- KR3 · Dec 2018 to Jan 2021
- Other international3 · Dec 2018 to Jan 2021
- Total international1 · Jan 2021
Product or service2 members · 186 facts
- Product94 · Jan 2017 to Jul 2026
- Service92 · Jan 2017 to Jul 2026
Statement geographicalus-gaap:StatementGeographicalAxis13 members · 78 facts
- CN8 · Jan 2011 to Dec 2017
- DE8 · Jan 2011 to Dec 2017
- FR8 · Jan 2011 to Dec 2017
- GB8 · Jan 2011 to Dec 2017
- IT8 · Jan 2011 to Dec 2017
- JP8 · Jan 2011 to Dec 2017
- Other International8 · Jan 2011 to Dec 2017
- Total International8 · Jan 2011 to Dec 2017
- US8 · Jan 2011 to Dec 2017
- IN3 · Jan 2016 to Dec 2017
- Americas1 · Apr 2018
- Asia1 · Apr 2018
- Europe1 · Apr 2018
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary41 claims from 10 reports · Sep 2024 to Jul 2026
- Management discussion (MD&A) commentary136 claims from 8 reports · Sep 2024 to Jul 2026
- Risk-factor changes4 claims from 1 reports · Dec 2025
- Risk factors48 risks from 2 annual reports · 2024 to 2025
Earnings calls
2 calls · May 2026 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 4, 2026
- FY2026 Q1May 5, 2026
Executive media
4 appearancesPodcasts, interviews and conference appearances by the company's executives, with their claims.
- Other appearances3 · Aug 2020 to Feb 2024
- TV interviews1 · Aug 2021
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.